CorMedix Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2008
Net Income	-46.34	-29.7	-28.21	-22.03	-43.54	-26.83	-33.01	-24.64	-18.22	-20.54	Upgrade
Depreciation & Amortization	0.07	0.08	0.06	0.13	0.07	0.07	0.04	0.03	0.02	0.02	Upgrade
Share-Based Compensation	5.49	4.07	5.04	2.5	2.44	1.11	1.66	1.34	3.23	2.17	Upgrade
Other Operating Activities	2.37	1.19	1.95	-2.57	-1.13	1.94	2.73	1.02	2.42	11.95	Upgrade
Operating Cash Flow	-38.41	-24.36	-21.16	-21.97	-15.05	-23.7	-28.59	-22.27	-12.53	-6.32	Upgrade
Capital Expenditures	-0.33	-0.22	-1.43	-0.11	-0.04	-0.05	-0.15	-0.06	-0.02	-0.03	Upgrade
Change in Investments	-16.73	-3.49	-7.71	7.54	-11.98	1.6	10.51	11.48	-23.59	0	Upgrade
Investing Cash Flow	-17.06	-3.71	-9.13	7.43	-12.02	1.56	10.36	11.42	-23.61	-0.03	Upgrade
Share Issuance / Repurchase	13.24	17.9	41.76	40.1	24.03	22.01	18.65	7.09	43.6	0.32	Upgrade
Debt Issued / Paid	0	0	0	0	0	7.39	0	0	0	-0	Upgrade
Other Financing Activities	42.68	-	-	-	1.77	-	1.88	-	0.03	8.04	Upgrade
Financing Cash Flow	55.92	17.9	41.76	40.1	25.8	29.4	20.52	7.09	43.63	8.36	Upgrade
Exchange Rate Effect	0	-0.01	-0.01	0.01	-0	-0.01	0.02	0	-0.02	-0.05	Upgrade
Net Cash Flow	0.45	-10.18	11.45	25.57	-1.27	7.24	2.32	-3.75	7.48	1.97	Upgrade
Free Cash Flow	-38.74	-24.58	-22.58	-22.08	-15.09	-23.75	-28.74	-22.32	-12.54	-6.35	Upgrade
Free Cash Flow Margin	-	-37573.53%	-11826.24%	-9229.69%	-5326.65%	-5525.74%	-8726.64%	-9961.45%	-5968.85%	-3352.93%	Upgrade
Free Cash Flow Per Share	-0.76	-0.61	-0.60	-0.77	-0.63	-1.33	-2.61	-2.94	-2.00	-1.48	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).